Hillhouse Capital Group
VC
INVESTOR TYPE
Active
STATUS
18
PROFESSIONALS
171
INVESTMENTS
117
PORTFOLIO
36
EXITS
Description
Hillhouse Capital Group is an investment management firm which seeks to manage capital for institutional clients such as university endowments, foundations, sovereign wealth funds, pensions and family offices. The firm prefers to make long-term equity investments with a focus on the consumer, telecom, media, technology, industrial and healthcare sectors. It was established in 2005 and is based in Beijing, China with an additional office in Central, Hong Kong.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2005
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Other Private Equity
Primary Office
- Floor 28, Building B, PingAn International Financial Center
- No. 1-3 Xinyuan South Road
- Beijing, Chaoyang District 100027
- China
+86 00000000000
Hillhouse Capital Group Investments (171)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Trumid Financial | 14-May-2019 | Later Stage VC | 0000 | Brokerage | Generating Revenue | |
| 000000000 | 09-May-2019 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | |
| 0000000 | 23-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 2 | |
| 000000000 | 09-Apr-2019 | 00000 00000 | 000.00 | Educational and Training Services (B2C) | Generating Revenue | |
| 000000000 | 25-Mar-2019 | 00000 00000 | 00000 | Financial Software | Generating Revenue | |
| 0000 | 04-Mar-2019 | 00000 00000 | 0000 | Vertical Market Software | Generating Revenue | |
| 0000 (00000 000000 | 04-Mar-2019 | 00000 00000 | 0000 | Human Capital Services | Generating Revenue | |
| 00000000 | 21-Feb-2019 | 00000 00000 | 00000 | Social/Platform Software | Generating Revenue | 00000 000 |
| Tal Education Group | 21-Feb-2019 | PIPE | 00000 | Education and Training Services (B2B) | Profitable | |
| HaiHe Biopharma | 12-Feb-2019 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 3 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Hillhouse Capital Group’s full profile, request a free trial.
Hillhouse Capital Group Exits (35)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Uber | 10-May-2019 | IPO | 00.00 | Completed |
|
| 00000000 | 09-May-2019 | 000 | 0000 | Completed |
|
| 0000000 000000 | 18-Apr-2019 | 000 | 0000 | Completed |
|
| 0000 00000 0000000 | 18-Apr-2019 | 000 | 00000 | Completed |
|
| 000000 00000000000 | 26-Feb-2019 | 000 | 00000 | Completed |
|
| 0000 000000000000 | 15-Feb-2019 | 000 | 0000 | Completed |
|
| 00000000 000 | 08-Feb-2019 | 000 | 00000 | Completed |
|
| 0000 000. | 06-Dec-2018 | 000 | 000.00 | Completed |
|
| Innovent Biologics | 31-Oct-2018 | IPO | 00000 | Completed |
|
| Arvinas | 27-Sep-2018 | IPO | 00000 | Completed |
|
Hillhouse Capital Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Hillhouse Capital Group‘s full profile, request access.
Request full access to PitchBookHillhouse Capital Group Team (26)
1 Former Team Member
You’re viewing 5 of 26 team members. Get the full list »Hillhouse Capital Group Co-Investors (355)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Sequoia Capital China | 14 | 0 | 0 |
| Tencent Holdings | 00 | 0 | 0 |
| Temasek Holdings | 0 | 0 | 0 |
| GGV Capital | 0 | 0 | |
| Qiming Venture Partners | 0 | 0 | 0 |